José M. Galbis

Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies <i>B2M</i> Inactivation Impairing Immunorecognition

Carolina Pereira, Pol Giménez‐Xavier, Eva Pros et al. · Clinical Cancer Research · 2016 · 101 citations

Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro

Lara Milián, Manuel Mata, Javier Alcácer et al. · PLoS ONE · 2020 · 101 citations · Full text

Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer

Rafael Sirera, Roy M. Bremnes, Andrea Cabrera‐Pastor et al. · Journal of Thoracic Oncology · 2011 · 99 citations · Full text

Prognostic Biomarkers, Oncology, Cancer Detection +9

CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC

Jeffrey H. Becker, Yandi Gao, Margaret Soucheray et al. · Cancer Research · 2019 · 61 citations · Full text

Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases

Salvador Benlloch, José M. Galbis, Cristina Alenda et al. · Annals of Oncology · 2008 · 55 citations · Full text

Cancer Detection, Molecular Markers, Medicine +10